Royal Enfield Indonesia CKD Plant Expansion Plan Under Evaluation

Royal Enfield Evaluates Indonesia CKD Assembly Plant

Royal Enfield Indonesia CKD Plant is being considered as the company evaluates ways to expand its presence in one of the world’s largest two-wheeler markets. The proposal comes as Royal Enfield faces import restrictions affecting exports from its Thailand CKD facility. B Govindarajan, CEO of Royal Enfield and Managing Director of Eicher Motors, informed investors that local assembly in Indonesia could help address quota limitations and support long-term international growth plans.

The company currently operates in Indonesia through a distributor-led business model but is studying a shift towards local CKD assembly. Govindarajan explained that exports from Thailand under the ASEAN trade framework continue to face quota restrictions in Indonesia. According to him, the company cannot sell more than around 10,000 vehicles annually due to these limitations, despite Indonesia representing a significant opportunity for premium motorcycle expansion.

Indonesia CKD Facility Assessment and Market Strategy

Royal Enfield has identified a local assembler in Indonesia and is evaluating the possibility of establishing a CKD operating plant in the country. The company highlighted that local content requirements are currently low, which could allow faster implementation if the project receives approval. The final decision regarding the assembly operation is expected after completing the ongoing assessment during the current quarter.

The potential Indonesia facility follows Royal Enfield’s broader international localisation strategy. Earlier, the company evaluated the feasibility of a CKD plant in Mexico after increased import tariffs affected its market approach. Local assembly enables manufacturers to reduce import barriers, improve market responsiveness, and create more competitive pricing structures in overseas regions.

Royal Enfield Global CKD Network Expansion

Royal Enfield currently operates seven CKD assembly units across international markets, including Argentina, Bangladesh, Colombia, Nepal, Thailand, and two facilities in Brazil. These plants collectively provide an annual assembly capacity of approximately 150,000 motorcycles. The network supports the company’s strategy of expanding globally while maintaining cost competitiveness and adapting production according to regional market conditions.

The motorcycle manufacturer has established operations across more than 80 countries through subsidiaries, CKD facilities, and a premium retail network exceeding 1,200 touchpoints. Markets such as Indonesia, Brazil, and other international regions remain important growth areas as the company continues strengthening its global footprint and premium motorcycle positioning.

Cost Challenges and International Business Growth

Govindarajan stated that local assembly would remove the first major hurdle related to import quotas but would not eliminate every cost challenge. He noted that Indonesia applies a luxury tax of around 140% or higher, which continues to impact motorcycle pricing. However, establishing a CKD operation could provide greater flexibility by allowing the company to overcome annual vehicle import restrictions.

Royal Enfield’s international business continues to show positive momentum, with overseas revenue exceeding Rs 1,000 crore for the first time during the June quarter. International markets contributed around 15% of total revenue, supported by strong performance in Brazil and other Latin American regions. The company continues exploring localisation opportunities to accelerate global growth and improve market competitiveness.

Frequently Asked Questions

Why is Royal Enfield considering an Indonesia CKD plant?
The proposed facility aims to overcome import restrictions and support expansion in Indonesia, where current Thailand exports face annual quota limitations. Royal Enfield is evaluating local assembly because Indonesia represents a large two-wheeler market and local content requirements remain low. The company believes a CKD operation could accelerate growth, improve supply flexibility, and strengthen its international manufacturing strategy while addressing regulatory barriers affecting vehicle imports.